Mount Sinai Institute of Technology (MSIT)––founded in December 2013––discovers, designs, develops, and delivers technology-based solutions for critical problems in biomedical science. Rather than being a pure discovery organization or a pure application organization, MSIT lies at the intersection of both areas.
Technology plays an increasingly important role in diagnosing and treating human disease. We are committed to developing novel biomedical technologies that will benefit patients. We emphasize multidisciplinary collaboration––bringing together scientists, physicians, designers, engineers, and entrepreneurs. We also partner with industry, academia, foundations, and the government to help shape public policies affecting biomedical technology development worldwide.
Our approach leverages the Icahn School of Medicine at Mount Sinai’s basic research institutes as well as its health and disease-related institutes and clinical departments. The School of Medicine, including the Graduate School of Biomedical Sciences, is currently recruiting students and faculty with expertise in quantitative sciences such as engineering, computer science, and applied mathematics, as well as other non-traditional backgrounds. These new recruits will help drive translational research initiatives using new tools, models, and approaches.